Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

CMMB

CMMB News

Newswire

08:02

Chemomab Announces Phase 2 Trial Results for Nebokitug in Primary Sclerosing Cholangitis Published in Gastroenterology Journal

15:33

Chemomab shares fall 10.37% intraday as cash runway through Q4 2026 raises financing concerns before Phase 3 trial.

13:58

Chemomab Advances Phase 3 Trial for Nebokitug, Targets Primary Sclerosing Cholangitis

08:08

Chemomab Therapeutics announces positive FDA feedback, advancing Nebokitug Phase 3 design.

08:04

Chemomab's Nebokitug Shows Favorable Safety, Consistent Biomarker Improvements in PSC Patients

View More

About CMMB

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More